Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"610"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22COVID-19+treatment%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
/vufind/Search/Results?lookfor=%22COVID-19+treatment%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
Search /vufind/Search2/Results?lookfor=%22COVID-19+treatment%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
PubPharm (111)
1
Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trial : Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care For Treatment of Moderate COVID-19 in Thailand : An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care For Treatment of Moderate COVID-19 in Thailand
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trial : Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care For Treatment of Moderate COVID-19 in Thailand : An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care For Treatment of Moderate COVID-19 in Thailand
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Hamburg Edoxaban foR anticoagulation in COvid-19 study : Hamburg Edoxaban foR anticoagulation in COvid-19 study - HERO-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Hamburg Edoxaban foR anticoagulation in COvid-19 study : Hamburg Edoxaban foR anticoagulation in COvid-19 study - HERO-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Short Title: Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)INSIGHT 012 : An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19 - Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study to Learn About a Repeat 5-Day Treatment with Nirmatrelvir/Ritonavir in People with Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment with Nirmatrelvir/Ritonavir : AN INTERVENTIONAL, EFFICACY AND SAFETY, PHASE 2, RANDOMIZED, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE A REPEAT 5-DAY COURSE OF NIRMATRELVIR/RITONAVIR COMPARED TO PLACEBO/RITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID-19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: 610
Medienart
111
Aufsätze
111
E-Artikel
111
E-Ressourcen
Zeitschriftentitel
108
WHO International Clinical Trials Registry Plat...
3
ClinicalTrials.gov
Thema
610
110
Study Type: Interventional
82
Phase: Phase 2
62
Recruitment Status: Authorised-recruitment may ...
41
Recruitment Status: Not yet recruiting
18
Medical Condition: Coronavirus Disease 2019 (CO...
18
Medical Condition: SARS-CoV-2 Infection MedDRA ...
18
Phase: Phase 3
10
Medical Condition: Moderate to severe coronavir...
6
Medical Condition: Subjects infected with SARS-...
6
Recruitment Status: Recruiting
4
Medical Condition: COVID-19 disease MedDRA vers...
4
Medical Condition: COVID-19 in hospitalized pat...
4
Medical Condition: Moderate COVID-19 MedDRA ver...
4
Medical Condition: Moderate to severe COVID-19 ...
4
Medical Condition: Subjects recently tested pos...
4
Phase: Phase 1
2
Medical Condition: COVID positive patients with...
2
Medical Condition: COVID-19 MedDRA version: 23....
2
Medical Condition: COVID-19 [Coronavirus diseas...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
20
2023
48
2022
32
2021
11
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
111
Englisch
Haven't found what you're looking for?
Wird geladen...